Tuesday, April 19, 2022
9:41 AM EST – Aeterna Zentaris Inc. : Today announced that European Patent Office has issued a patent providing intellectual property protection of macimorelin in 27 countries within the European Union as well as additional European non-EU countries, such as the UK and Turkey, for macimorelin (Ghryvelin®; Macrilen™) for use to diagnose growth hormone deficiency (GHD) in adults. Aeterna Zentaris Inc (T.AEZS) shares were unchanged at 0.41.
Stocks in Play: Aeterna Zentaris Inc., Tue, 19 Apr 2022 09:42:07 EST